Emerillon Therapeutics

Emerillon Therapeutics is a biotechnology company dedicated to the discovery and development of infectious disease drugs through genomics. The company uses its Recombinant Congenic Strains (RCS) mouse platform technology to discover and develop drugs for complex human diseases. Its RCS mouse platform focuses on identifying drug targets in the fields of pain, atherosclerosis, osteoporosis, and epilepsy.